AAA Callum Cyrus – Page 8

Apogen ups series B round to $11m

Apogen Biotechnologies, a US-based oncology therapy spinout of University of Minnesota, boosted its series A round to $11m yesterday with $4m from investors including pharmaceutical firm Merck Group. Merck invested through corporate venturing subsidiary M Ventures, participating alongside unnamed existing investors. Pharmaceutical firms Eli Lilly, WuXi AppTec, AbbVie and Johnson & Johnson all contributed to… Continue reading Apogen ups series B round to $11m